FDA chief pledges changes to DTC advertising guidelines

Article Abstract:

The Food and Drug Administration (FDA) is working to improve rules governing direct-to-consumer (DTC) advertising of prescription drugs. It is proposed that FDA warning letters will strengthen enforcement efforts in legal actions, providing more effective prevention to the recurrent patterns of misleading advertising.

Government regulation (cont), Government regulation, HEALTH SERVICES, Drugs, Laws, regulations and rules, Powers and duties, Prescriptions (Drugs), United States. Food and Drug Administration, Nonprescription drugs

---

U.S. SARS cases still rare, but worries are more common

Article Abstract:

People in the US are concerned about getting severe acute respiratory syndrome even though there have been fewer cases than in other parts of the world.

Management dynamics, Public affairs, Management, Case studies, Public opinion, Company business management, Health attitudes, Severe acute respiratory syndrome

---

Fast-food sellers under fire for supersizing people

Article Abstract:

Possible litigation against fast food manufacturers and purveyors is discussed by John F. Banzhaf III.

Eating places, Restaurants & Food Service, Food Services and Drinking Places, Fast Food Restaurants, Limited-Service Restaurants, Causes of, Restaurant industry, Interview, Beliefs, opinions and attitudes, Obesity, Banzhaf, John F., III

Similar abstracts:

• Abstracts: Drug firm events linked to changes in prescribing habits. Survey studies doctor autonomy, control in groups. Disclosure of Rx drug records raises concerns
• Abstracts: Feds closely scrutinizing recruitment incentives. Hospitalists join ranks of specialists most in demand today
• Abstracts: Diabetes group looks outside U.S. for stem cell research. Ethics committees help with tough choices. Dr. Caplan shares his take on medical ethics
• Abstracts: Getting patients to pay. Aetna plans tiers based on cost, quality. Learning for earning
• Abstracts: Cancer center called sham, closed down. Tamoxifen: 25-year success story looking for a sequel. Gene mutations present clues for cancer-drug design

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.